From Basic Science to Better Medicines: A Round-Table Discussion with Congresswoman Katherine Clark - April 23, 2018

Ekaterina Cleary, Bentley research associate and lead author of the study; Deborah Dunsire, CEO of Xtuit Pharmaceuticals; Chris Garabedian, CEO of Xontogeny; Mark Namchuk, senior vice president of Research, Pharmaceutical and Non-clinical Development at Alkermes; and Lance Colwell '92, vice president of the U.S. Rare Disease Group at Biogen.